The Patent Finder
US

Trilobine and Its Natural Analogs for Use as a Drug

US 10,517,863 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Pierre Fabre Medicament S.A.S., which filed it. The recorded assignments below show how it moved.

Term ends Oct 3, 2036 · High confidence

Held by Pierre Fabre Medicament and Centre National de la Recherche Scientifique (CNRS)
Filed Mar 30, 2018 · Granted Dec 31, 2019
Base term, 20 years from filing
Today
20 years from filing
2016 2036
Clock starts
Oct 3, 2016
Term ends
Oct 3, 2036
Granted
Dec 31, 2019
base term fee events Computed Oct 24, 2026 · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Applications in this family
Applications sharing this one's continuity chain.

This patent's term is the statutory base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 3, 2016Oct 3, 2036High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 3, 2036High confidence

This family

US 10,517,863this patent
Oct 2036
Oct 2036
1 of 2 applications in this family shown, earliest filings first.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 1, 2018
Reel 45966, frame 199
Menon, Yoann; Long, Christophe; Sautel, François; Arimondo, Paola B.Pierre Fabre Medicament; Centre National de la Recherche Scientifique (CNRS)Assignment of Assignor's Interest
Jun 1, 2018
reel/frame not recorded
Menon, Yoann; Sautel, François; Arimondo, Paola B.; Long, ChristophePierre Fabre MedicamentAssignment of Assignor's Interest
Jun 1, 2018
reel/frame not recorded
Menon, Yoann; Sautel, François; Arimondo, Paola B.; Long, ChristopheCentre National de la Recherche Scientifique (CNRS)Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

Maintenance fee events come from USPTO's own fee records. USPTO does not publish a per-patent fee page, so there is nothing to link to.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.

What's changing

Citations

0
later US patents cite this one
Fewer than half of the utility patents granted in 2019 in our data have been cited yet, so we show the count and do not rank on it. How we rank
Every date shows its work: base rule, PTA, PTE, disclaimer caps, fee overlay, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Part of 137 Finder · © 2026 137 Finder LLC · Sources cited